Raptor Announces NIDDK Provides Additional Data From CyNCh Study Evaluating RP103 in Pediatric NASH at AASLD

By: via Benzinga
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) today announced researchers have provided additional results from the CyNCh study of RP103 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.